Can Bentyl Cause Nausea?
Yes, dicyclomine (Bentyl) can cause nausea as a documented side effect, occurring in approximately 14% of patients in controlled clinical trials, compared to 6% with placebo. 1
Evidence from FDA Drug Label
The FDA-approved prescribing information for Bentyl explicitly lists nausea as a recognized adverse effect. In controlled clinical trials involving over 100 patients treated for functional bowel/irritable bowel syndrome with dicyclomine hydrochloride at 160 mg daily (40 mg four times daily):
- Nausea occurred in 14% of patients taking dicyclomine versus 6% taking placebo 1
- This represents more than double the placebo rate
- Nausea was among the most common side effects, ranking fourth after dry mouth (33%), dizziness (29%), and blurred vision (27%)
Clinical Context and Mechanism
Dicyclomine is an anticholinergic/antispasmodic agent used to treat irritable bowel syndrome-associated abdominal pain. The nausea likely results from its anticholinergic properties, which can affect gastrointestinal motility and function 1. This is somewhat paradoxical since the drug is used to treat GI symptoms, but anticholinergic effects on the upper GI tract can trigger nausea in susceptible individuals.
Management Considerations
- Most side effects were tolerated or resolved: In 41% of patients experiencing side effects, symptoms either disappeared or were tolerated at the full 160 mg daily dose 1
- Dose reduction may help: 46% of patients with side effects required dose reduction to an average of 90 mg daily but continued to experience favorable clinical response with resolution or tolerance of side effects 1
- Discontinuation rate: Only 9% of patients discontinued the drug due to side effects (compared to 2% with placebo) 1
Important Safety Information
Beyond nausea, clinicians should be aware that dicyclomine carries additional warnings:
- CNS effects including drowsiness, dizziness, and confusion can occur 1
- Contraindicated in infants less than 6 months and nursing mothers 1
- Intravenous administration should be avoided due to thrombosis risk 2
Bottom line: If a patient develops nausea on Bentyl, consider dose reduction before discontinuation, as many patients can continue therapy successfully at lower doses while maintaining therapeutic benefit.